Interestingly, we found that targeting AGT may enhance the efficacy of the chemotherapy of GC, suggesting that AGT may be a prognostic biomarker for GC patients and could serve as a potential target to increase the efficacy of chemotherapy for GC treatment. This evidence concerns the gene AGT and gastric cancer.